Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! [PDF]
Eur J Obstet Gynecol Reprod Biol, 2020 Rozenberg S +4 more
europepmc +1 more source
Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas: A Randomized Controlled Trial. [PDF]
Obstet Gynecol, 2019 Lukes AS +6 more
europepmc +1 more source
Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas: A Randomized Controlled Trial. [PDF]
Obstet Gynecol, 2018 Simon JA +6 more
europepmc +1 more source
Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports. [PDF]
Medicine (Baltimore), 2018 Santoro A +7 more
europepmc +1 more source
Corrigendum to "Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate". [PDF]
Biomed Res Int, 2018 Rabe T +6 more
europepmc +1 more source
Ulipristal Acetate for Unscheduled Bleeding in Etonogestrel Implant Users: A Randomized Controlled Trial. [PDF]
Obstet Gynecol, 2018 Zigler RE +4 more
europepmc +1 more source
Pharmacy access to Ulipristal acetate in major cities throughout the United States. [PDF]
Contraception, 2018 Shigesato M +6 more
europepmc +1 more source
1,25 Dihydroxyvitamin D3 Enhances the Antifibroid Effects of Ulipristal Acetate in Human Uterine Fibroids. [PDF]
Reprod Sci, 2019 Ali M +4 more
europepmc +1 more source